Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
about
Polymer-drug conjugates: origins, progress to date and future directionsCo-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.Targeting ABCB1-mediated tumor multidrug resistance by CRISPR/Cas9-based genome editingDrug and gene co-delivery systems for cancer treatment.Design of smart HPMA copolymer-based nanomedicines.pH-Responsive single walled carbon nanotube dispersion for target specific release of doxorubicin to cancer cells.
P2860
Targeting of multidrug-resistant human ovarian carcinoma cells with anti-P-glycoprotein antibody conjugates.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@ast
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@en
type
label
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@ast
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@en
prefLabel
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@ast
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@en
P2860
P356
P1476
Targeting of multidrug-resista ...... coprotein antibody conjugates.
@en
P2093
Jindřich Kopeček
Kirk D Fowers
P2860
P304
P356
10.1002/MABI.201100350
P577
2012-01-25T00:00:00Z